In a studyExternal link published in the medical journal Cell on Thursday, researchers from the Paul Scherrer Institute in partnership with the Swiss pharmaceutical company Roche were able to decipher the structure of the chemokine receptor 7 (CCR7) – a special membrane protein that helps white blood cells travel through the body.
Receptors like CCR7 can interact with more than 40 signaling proteins called chemokines that cause cells to move. Cancer cells can use the receptor to guide them into the lymphatic system, spreading the cancer throughout the body. These secondary tumors called metastases are responsible for around 90% of deaths in cancer patients.
With this discoveryExternal link, researchers have established a key foundation for the development of a drug that could prevent metastasis in certain prevalent cancer types, such as colorectal cancer.
Scientific collaboration
To uncover the receptor’s structure, researchers used X-ray crystallography at the Swiss Light SourceExternal link, a particle accelerator set up in 2001 that provides photon beams of high brightness for research in materials science, biology and chemistry.
With information about the precise structure of the receptor, the researchers were able to identify a molecule that blocks the receptor and thus prevents a signal from being transmitted into the cell.
“Our experiments show that the artificial molecule, inside the cell, binds to the receptor. This keeps the chain reaction that leads to cell migration from getting started”, explained Steffen Brünle, a postdoctoral researcher at the institute who was part of the study team.
Using the structure of the receptor, Roche scientists searched for agents in its database of millions of molecules that could potentially block the signaling protein. This led to the identification of five possible compounds that could be used to develop cancer drugs.
The Paul Scherrer Institute is part of the network of federal technology institutes and is the largest research institute in the country, employing 2,100 people. The annual budget amounts to approximately CHF407 million.
More
More
“Rolls-Royce” of x-ray machines honoured
This content was published on
The Swiss Light Source (SLS) is the sparkling jewel in the crown of the Paul Scherrer Institute (PSI), Switzerland’s largest research institution – although the path to its creation couldn’t have been bumpier. Since summer 2001, thousands of experiments have been carried out – by pharmaceutical researchers as well as academics – resulting in more…
What can be done to protect biodiversity in your country?
Swiss voters are set to decide on a people’s initiative calling for better protection of ecosystems in the country. Have your say on the September 22 vote.
Swiss investigate four people linked to Russian oligarch
This content was published on
The Office of the Attorney General of Switzerland is investigating four individuals linked to Russian oligarch Suleyman Kerimov.
Swiss government scrambles to deal with egg shortage
This content was published on
From September 1, more eggs intended for consumption may be imported into Switzerland. In allowing this, the government wants to secure the supply of eggs for consumers.
This content was published on
Agricultural research sees new development opportunities for Swiss sparkling wines in the face of declining wine consumption. In a survey, half of consumers expressed a willingness to pay more for local products than for foreign ones.
Locarno spotlights filmmakers from South America and Caribbean
This content was published on
The Open Doors section of the Locarno Film Festival has named the winners for 2024. The spotlight is on the South American and Caribbean regions.
Storm paralyses trains to popular Swiss tourist resort
This content was published on
The railway line between Zweilütschinen and Grindelwald in central Switzerland is expected to remain closed until Friday following heavy rains.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
The pharma holy grail: drugs for you, designed by you
This content was published on
In the age of sensors, wearables, and artificial intelligence (AI), almost everything can be customised for the individual.
Flipping the world: atomic compass points east-west
This content was published on
Swiss researchers have discovered a new magnetic phenomenon, observed on a micro-level, that could have implications for computer development.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.